↓ Skip to main content

The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development

Overview of attention for article published in Therapeutic Advances in Hematology, August 2011
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#2 of 402)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
48 news outlets
blogs
4 blogs
policy
1 policy source
twitter
52 X users
patent
11 patents
reddit
18 Redditors
video
1 YouTube creator
bluesky
2 Bluesky users
podcasts
2 podcasts

Readers on

mendeley
518 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
Published in
Therapeutic Advances in Hematology, August 2011
DOI 10.1177/2040620711413165
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 52 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 518 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Brazil 1 <1%
Unknown 517 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 86 17%
Student > Master 46 9%
Student > Ph. D. Student 38 7%
Researcher 28 5%
Other 18 3%
Other 44 8%
Unknown 258 50%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 54 10%
Medicine and Dentistry 43 8%
Chemistry 42 8%
Pharmacology, Toxicology and Pharmaceutical Science 27 5%
Agricultural and Biological Sciences 24 5%
Other 63 12%
Unknown 265 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 443. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 September 2026.
All research outputs
#80,940
of 34,516,376 outputs
Outputs from Therapeutic Advances in Hematology
#2
of 402 outputs
Outputs of similar age
#236
of 168,280 outputs
Outputs of similar age from Therapeutic Advances in Hematology
#1
of 8 outputs
Altmetric has tracked 34,516,376 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 402 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,280 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them